Company News

Company News

Biointron Recognized with 2024 Scientist.com Supplier Performance Recognition Award!

Biointron Recognized with 2024 Scientist.com Supplier Performance Recognition Award!

Biointron is proud to share that we have received the 2024 Scientist.com Supplier Performance Recognition Award, for our dedication to providing high-quality drug discovery research services on this industry-renowned R&D sourcing platform.

Feb 07, 2025
Biointron Achieves High Certification in Third-Party Risk Assessment Conducted by CyberVadis

Biointron Achieves High Certification in Third-Party Risk Assessment Conducted by CyberVadis

This comprehensive assessment, which evaluated our entire organization and all functions, underscores our commitment to excellence in cybersecurity and risk management. CyberVadis is a leading global provider of independent cybersecurity assessment services, and their rigorous evaluation process includes international standards such as ISO 2700x, NIST Cybersecurity Framework, ICS Cybersecurity, and GDPR.

Aug 05, 2024
Cyagen and Biointron Forge Strategic Alliance, Opening a New Chapter in Antibody Drug Development

Cyagen and Biointron Forge Strategic Alliance, Opening a New Chapter in Antibody Drug Development

In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#

Mar 23, 2024
FatiAbGen and Biointron Announce a Strategic Alliance in Korea

FatiAbGen and Biointron Announce a Strategic Alliance in Korea

Biointron is proud to announce a strategic partnership with FatiAbGen, a leading biotechnology firm focused on antibody-based therapeutics. As the newly appointed Korean distributor for Biointron, FatiAbGen will be at the forefront of delivering Biointron’s products to the Korean market.

Mar 15, 2024
Celebrating International Women’s Day

Celebrating International Women’s Day

Celebrate International Women's Day with Biointron's female workforce!

Mar 15, 2024
Biointron Announces the Official Launch of Afucosylated Antibody Expression Platform!

Biointron Announces the Official Launch of Afucosylated Antibody Expression Platform!

Biointron is excited to announce our newly launched CHOK1-Fut8KO expression platform for afucosylated antibodies.

Aug 10, 2023
AstraZeneca Delegations Visit Biointron Shanghai R&D Center

AstraZeneca Delegations Visit Biointron Shanghai R&D Center

On March 21st, Biointron Biological Shanghai R&D Center welcomed AstraZeneca delegations Mark Cobbold, Margie Li, Hao Huang, and Yingjie Wu for an on-site visit.

Mar 21, 2023
Biointron Raises $75M in Series B Funding

Biointron Raises $75M in Series B Funding

Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.

Sep 02, 2022

Keep yourself updated with Biointron Insights

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.